Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injection of Autologous CD34+ Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF < 40%

NCT00346177 is registered in ClinicalTrials.gov with Losordo, Douglas, M.D. as lead sponsor.

NCT NCT00346177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00346177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injection of Autologous CD34+ Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF < 40%
Lead sponsor
Losordo, Douglas, M.D.
Phase
Phase 2
Overall status
Withdrawn
Start date
September 30, 2010
Completion date
September 30, 2012
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, congestive heart failure, myocardial ischemia